Replies to post #289735 on Innovation Pharmaceuticals Inc (IPIX)

[Patientspeople]

" ...received data supporting Brilacidin’s direct inhibition of SARS-CoV-2"
http://www.ipharminc.com/press-release/2020/4/1/innovation-pharmaceuticals-receives-data-supporting-brilacidins-direct-inhibition-of-sars-cov-2-the-novel-coronavirus-responsible-for-covid-19

general information:
Direct-acting antivirals (DAAs) are a newer class of drugs. DAAs target specific steps in the virus life cycle. DAAs have shorter treatment times, fewer side effects, and higher SVR (sustained virologic response) rates than older drugs.

for more info:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323075/